NecroX-7 | free radical scavenger | HMGB1 | high-mobility group box 1 | inhibitor | CAS#1120332-55-9

MedKoo Cat#: 127009 | Name: NecroX-7

Description:

WARNING: This product is for research use only, not for human or veterinary use.

NecroX-7 is a potent free radical scavenger and a HMGB1 (high-mobility group box 1) inhibitor.

Chemical Structure

NecroX-7

CAS#1120332-55-9

Theoretical Analysis

MedKoo Cat#: 127009

Name: NecroX-7

CAS#: 1120332-55-9

Chemical Formula: C24H29N3O3S

Exact Mass: 439.1930

Molecular Weight: 439.57

Elemental Analysis: C, 65.58; H, 6.65; N, 9.56; O, 10.92; S, 7.29

Price and Availability

Size	Price	Availability
100mg	USD 1,250.00	2 Weeks
500mg	USD 3,650.00	2 Weeks
1g	USD 5,250.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

NecroX-7; NecroX-7; NecroX-7

IUPAC/Chemical Name

4-((2-phenyl-7-((tetrahydro-2H-pyran-4-yl)amino)-1H-indol-5-yl)methyl)thiomorpholine 1,1-dioxide

InChi Key

UZRCNCPUOFYHRB-UHFFFAOYSA-N

InChi Code

InChI=1S/C24H29N3O3S/c28-31(29)12-8-27(9-13-31)17-18-14-20-16-22(19-4-2-1-3-5-19)26-24(20)23(15-18)25-21-6-10-30-11-7-21/h1-5,14-16,21,25-26H,6-13,17H2

SMILES Code

O=S1(CCN(CC1)CC2=CC3=C(C(NC4CCOCC4)=C2)NC(C5=CC=CC=C5)=C3)=O

Appearance

To be determined

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Biological target:

HMGB1 inhibitor

In vitro activity:

NecroX-7-mediated morphologic changes of astrocytes were seen in both in vitro and in vivo models of TLE. Finally, western blot analysis demonstrated that NecroX-7 post-treatment after acute seizures could decrease the expression of mixed lineage kinase domain-like pseudokinase (MLKL) and phosphorylated MLKL (p-MLKL), markers for necroptosis. Taken all together, NecroX-7 has potential as a novel medication for TLE with its neuroprotective, anti-inflammatory, and anti-necroptotic effects. Reference: Roh Y, Lee SB, Kim M, Kim MH, Kim HJ, Cho KO. Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures. Front Pharmacol. 2023 Aug 2;14:1187819. doi: 10.3389/fphar.2023.1187819. PMID: 37601059; PMCID: PMC10433749.

In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 439.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Grootaert MOJ, Schrijvers DM, Van Spaendonk H, Breynaert A, Hermans N, Van Hoof VO, Takahashi N, Vandenabeele P, Kim SH, De Meyer GRY, Martinet W. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Atherosclerosis. 2016 Sep;252:166-174. doi: 10.1016/j.atherosclerosis.2016.06.045. Epub 2016 Jul 2. PMID: 27425215. 2: Roh Y, Lee SB, Kim M, Kim MH, Kim HJ, Cho KO. Alleviation of hippocampal necroptosis and neuroinflammation by NecroX-7 treatment after acute seizures. Front Pharmacol. 2023 Aug 2;14:1187819. doi: 10.3389/fphar.2023.1187819. PMID: 37601059; PMCID: PMC10433749. 3: Park J, Park E, Ahn BH, Kim HJ, Park JH, Koo SY, Kwak HS, Park HS, Kim DW, Song M, Yim HJ, Seo DO, Kim SH. NecroX-7 prevents oxidative stress-induced cardiomyopathy by inhibition of NADPH oxidase activity in rats. Toxicol Appl Pharmacol. 2012 Aug 15;263(1):1-6. doi: 10.1016/j.taap.2012.05.014. Epub 2012 May 31. PMID: 22659508. 4: Chung HK, Kim YK, Park JH, Ryu MJ, Chang JY, Hwang JH, Lee CH, Kim SH, Kim HJ, Kweon GR, Kim KS, Shong M. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Liver Int. 2015 Apr;35(4):1341-53. doi: 10.1111/liv.12741. Epub 2015 Jan 10. PMID: 25443620. 5: Jin SA, Kim SK, Seo HJ, Jeong JY, Ahn KT, Kim JH, Choi DE, Park JH, Lee JH, Choi SW, Seong IW, Kim SH, Suh KS, Jeong JO. Beneficial Effects of Necrosis Modulator, Indole Derivative NecroX-7, on Renal Ischemia-Reperfusion Injury in Rats. Transplant Proc. 2016 Jan-Feb;48(1):199-204. doi: 10.1016/j.transproceed.2015.12.018. PMID: 26915868. 6: Kim HJ, Yoon KA, Lee MK, Kim SH, Lee IK, Kim SY. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression. Life Sci. 2012 Nov 2;91(19-20):928-34. doi: 10.1016/j.lfs.2012.09.009. Epub 2012 Sep 20. PMID: 23000100. 7: Biswas SK. NecroX-7 may appear as a new molecule to stabilize atherosclerotic plaques. Atherosclerosis. 2016 Sep;252:190-191. doi: 10.1016/j.atherosclerosis.2016.07.917. Epub 2016 Jul 25. PMID: 27477187. 8: Lee JH, Park KM, Lee YJ, Kim JH, Kim SH. A New Chemical Compound, NecroX-7, Acts as a Necrosis Modulator by Inhibiting High-Mobility Group Box 1 Protein Release During Massive Ischemia-Reperfusion Injury. Transplant Proc. 2016 Dec;48(10):3406-3414. doi: 10.1016/j.transproceed.2016.09.046. PMID: 27931589. 9: Choi JM, Park KM, Kim SH, Hwang DW, Chon SH, Lee JH, Lee SY, Lee YJ. Effect of necrosis modulator necrox-7 on hepatic ischemia-reperfusion injury in beagle dogs. Transplant Proc. 2010 Nov;42(9):3414-21. doi: 10.1016/j.transproceed.2010.08.050. PMID: 21094788. 10: Im KI, Nam YS, Kim N, Song Y, Lee ES, Lim JY, Jeon YW, Cho SG. Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis. Mucosal Immunol. 2019 Sep;12(5):1070-1081. doi: 10.1038/s41385-019-0132-x. Epub 2019 Jan 15. PMID: 30647411. 11: Im KI, Kim N, Lim JY, Nam YS, Lee ES, Kim EJ, Kim HJ, Kim SH, Cho SG. The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release. J Immunol. 2015 Jun 1;194(11):5223-32. doi: 10.4049/jimmunol.1402609. Epub 2015 Apr 24. PMID: 25911749; PMCID: PMC4432727. 12: Hwang IC, Kim JY, Kim JH, Lee JE, Seo JY, Lee JW, Park J, Yang HM, Kim SH, Cho HJ, Kim HS. Therapeutic Potential of a Novel Necrosis Inhibitor, 7-Amino- Indole, in Myocardial Ischemia-Reperfusion Injury. Hypertension. 2018 Jun;71(6):1143-1155. doi: 10.1161/HYPERTENSIONAHA.117.09405. Epub 2018 Apr 16. PMID: 29661840; PMCID: PMC5959205. 13: Kim G, Lee HS, Oh BJ, Kwon Y, Kim H, Ha S, Jin SM, Kim JH. Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation. Am J Transplant. 2021 Apr;21(4):1440-1452. doi: 10.1111/ajt.16323. Epub 2020 Nov 10. PMID: 32978875. 14: Kim D, Koo JS, Kim SH, Park YS, Choe JW, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ. The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice. Pharmaceutics. 2023 Jan 9;15(1):222. doi: 10.3390/pharmaceutics15010222. PMID: 36678851; PMCID: PMC9862178. 15: Park JH, Seo KS, Tadi S, Ahn BH, Lee JU, Heo JY, Han J, Song MS, Kim SH, Yim YH, Choi HS, Shong M, Kweon G. An indole derivative protects against acetaminophen-induced liver injury by directly binding to N-acetyl-p- benzoquinone imine in mice. Antioxid Redox Signal. 2013 May 10;18(14):1713-22. doi: 10.1089/ars.2012.4677. Epub 2012 Dec 19. PMID: 23121402; PMCID: PMC3619205. 16: Lu Y, Shen Z, Xu Y, Lin H, Shen L, Jin Y, Guo Y, Lu J, Li L, Zhuang Y, Jin Y, Zhuang W, Huang W, Dong X, Dai H, Che J. Discovery of New Phenyltetrazolium Derivatives as Ferroptosis Inhibitors for Treating Ischemic Stroke: An Example Development from Free Radical Scavengers. J Med Chem. 2024 Jul 25;67(14):11712-11731. doi: 10.1021/acs.jmedchem.4c00211. Epub 2024 Jul 12. PMID: 38996382.